Literature DB >> 35563798

The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications.

Chia-Hsin Hsu1,2, Keng-Jung Lee3, Yi-Han Chiu4, Kuo-Ching Huang5, Guo-Shou Wang6, Lei-Po Chen7, Kuang-Wen Liao6, Chen-Si Lin1.   

Abstract

Lysosomes are membrane-bound vesicles that play roles in the degradation and recycling of cellular waste and homeostasis maintenance within cells. False alterations of lysosomal functions can lead to broad detrimental effects and cause various diseases, including cancers. Cancer cells that are rapidly proliferative and invasive are highly dependent on effective lysosomal function. Malignant melanoma is the most lethal form of skin cancer, with high metastasis characteristics, drug resistance, and aggressiveness. It is critical to understand the role of lysosomes in melanoma pathogenesis in order to improve the outcomes of melanoma patients. In this mini-review, we compile our current knowledge of lysosomes' role in tumorigenesis, progression, therapy resistance, and the current treatment strategies related to lysosomes in melanoma.

Entities:  

Keywords:  chemoresistance; lysosome biogenesis; melanoma therapy target

Mesh:

Year:  2022        PMID: 35563798      PMCID: PMC9103375          DOI: 10.3390/cells11091492

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   7.666


  77 in total

1.  "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin.

Authors:  N Guinec; V Dalet-Fumeron; M Pagano
Journal:  Biol Chem Hoppe Seyler       Date:  1993-12

2.  RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.

Authors:  Direna Alonso-Curbelo; Erica Riveiro-Falkenbach; Eva Pérez-Guijarro; Metehan Cifdaloz; Panagiotis Karras; Lisa Osterloh; Diego Megías; Estela Cañón; Tonantzin G Calvo; David Olmeda; Gonzalo Gómez-López; Osvaldo Graña; Víctor Javier Sánchez-Arévalo Lobo; David G Pisano; Hao-Wei Wang; Pablo Ortiz-Romero; Damià Tormo; Keith Hoek; José L Rodríguez-Peralto; Johanna A Joyce; María S Soengas
Journal:  Cancer Cell       Date:  2014-06-26       Impact factor: 31.743

Review 3.  Apoptosis and melanoma chemoresistance.

Authors:  María S Soengas; Scott W Lowe
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

Review 4.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

Review 5.  Cathepsin B and its role(s) in cancer progression.

Authors:  Izabela Podgorski; Bonnie F Sloane
Journal:  Biochem Soc Symp       Date:  2003

6.  Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study.

Authors:  Paola Matarrese; Barbara Ascione; Laura Ciarlo; Rosa Vona; Carlo Leonetti; Marco Scarsella; Anna M Mileo; Caterina Catricalà; Marco G Paggi; Walter Malorni
Journal:  Mol Cancer       Date:  2010-08-04       Impact factor: 27.401

Review 7.  Melanoma treatment in review.

Authors:  Beatriz Domingues; José Manuel Lopes; Paula Soares; Helena Pópulo
Journal:  Immunotargets Ther       Date:  2018-06-07

Review 8.  Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.

Authors:  Dorina Coricovac; Cristina Dehelean; Elena-Alina Moaca; Iulia Pinzaru; Tiberiu Bratu; Dan Navolan; Ovidiu Boruga
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

9.  Paraoxonase-2: A potential biomarker for skin cancer aggressiveness.

Authors:  Tiziana Bacchetti; Eleonora Salvolini; Veronica Pompei; Roberto Campagna; Elisa Molinelli; Valerio Brisigotti; Lucrezia Togni; Guendalina Lucarini; Davide Sartini; Anna Campanati; Monica Mattioli-Belmonte; Corrado Rubini; Gianna Ferretti; Annamaria Offidani; Monica Emanuelli
Journal:  Eur J Clin Invest       Date:  2020-12-01       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.